RARITAN, NJ--(Marketwired - Aug 18, 2015) - Ortho Clinical Diagnostics today announced that it obtained 510(k) clearance for the ORTHO VISION™ Analyzer, a highly interactive, fully automated analyzer ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

RARITAN, N.J., April 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been recognized with a ...

RARITAN, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient ...

RARITAN, N.J.--(BUSINESS WIRE)--Ortho Clinical Diagnostics today announced the appointments of accomplished industry veterans Carl Hull, Ron Labrum, Thomas Mac Mahon and José (Joe) E. Almeida as ...

RARITAN, N.J., Sept. 27, 2021 /CNW/ -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced the availability of ...

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest ...

(MENAFN- Market Press Release) March 12, 2026 1:45 am - Discover Orthodontics highlights advanced orthodontic diagnostics with the iTero Element Scanner, delivering comfortable digital impressions, ...

Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS ...

-- Ortho is the first company to have an EUA for both a quantitative IgG antibody assay targeting the spike protein and a total assay targeting the nucleocapsid protein. This new antibody test is the ...

Ortho Clinical Diagnostics Holdings plc, an in-vitro diagnostics company, has raised $1.3 billion for its IPO after pricing its 76 million shares at $17 per share. The stock began trading January 28, ...

Carlyle Group is exploring a sale or initial public offering of Ortho-Clinical Diagnostics, which could be valued at more than $7 billion, including debt. A divestment of Ortho-Clinical Diagnostics ...